Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 6, 2003, Pages 895-906

  Eriksson, David ^a   Joniani, Homa Mirzaie ^a   Sheikholvaezin, Ali ^a   Löfroth, Per Olov ^a   Johansson, Lennart ^a   Ählström, Katrine Riklund ^a   Stigbrand, Torgny ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Combination therapy; Experimental tumours; Radiation induced cell death; Radioimmunotherapy; Radiotherapy

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKERATIN; ENDOGLIN; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY H7 I 131; MONOCLONAL ANTIBODY I 131; MONOCLONAL ANTIBODY TS1 I 131; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HELA CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; RADIATION DOSE; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME; TUMOR VOLUME; VASCULARIZATION;

EID: 0038714405     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1177-2     Document Type: Article

References (41)

1. Witzig TE. Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma. Cancer Chemother Pharmacol 2001;48 Suppl 1:S91-S95.
2. White CA, Berlfein JR, Grillo-Lopez AJ. Antibody-targeted immunotherapy for treatment of non-Hodgkin's lymphoma. Curr Pharm Biotechnol 2000; 1:303-312.
3. Goldenberg DM. The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy. Crit Rev Oncol Hematol 2001; 39:195-201.
4. Postema EJ, Boerman OC, Oyen WJ, Raemaekers JM, Corstens FH. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma. Eur J Nucl Med 2001; 28:1725-1735.
5. 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood 2000; 96:1259-1266.
6. 125I-labeled antibody at experimental radioimmunotargeting. Cancer 1997; 80:2510-2518.
7. Rossi Norrlund R, Ullen A, Sandstrom P, Holback D, Johansson L, Stigbrand T, Hietala SO, Riklund Ahlstrom K. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies. Cancer 1997; 80:2681-2688.
8. 125I-labeled and anti-idiotypic anti placental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting. Improving experimental tumor radioimmunotargeting. Thesis, Umea University, 1997.
9. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001; 49:379-389.
10. Wouters BG, Sy AM, Skarsgard LD. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat Res 1996; 146:399-413.
11. 60Co gamma rays on human tumor cells in vitro. Radiat Res 2002; 158:311-318.
12. Mirzaie-Joniani H, Eriksson D, Johansson A, Lofroth PO, Johansson L, Ahlstrom KR, Stigbrand T. Apoptosis in HeLa Hep2 cells is induced by low-dose, low-dose-rate radiation. Radiat Res 2002; 158:634-640.
13. Mirzaie-Joniani H, Eriksson D, Sheikholvaezin A, Johansson A, Lofroth PO, Johansson L, Stigbrand T. Apoptosis induced by low-dose and low-dose-rate radiation. Cancer 2002; 94:1210-1214.
14. Stigbrand T, Fishman WH. Progress in clinical and biological research. New York: Alan R. Liss, 1984.
15. 131I-labeled anti-PLAP monoclonal antibodies. Acta Radiol 1991; 32:375-380.
16. Stigbrand T, Hietala SO, Johansson B, Makiya R, Riklund K, Ekelund L. Tumour radioimmunolocalization in nude mice by use of antiplacental alkaline phosphatase monoclonal antibodies. Tumour Biol 1989; 10:243-251.
17. Jeppsson A, Wahren B, Millan JL, Stigbrand T. Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase. Br J Cancer 1984; 49:123-128.
18. Johansson A, Eriksson D, Ullen A, Lofroth PO, Johansson L, Riklund-Ahlstrom K, Stigbrand T. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody. Cancer 2002; 94:1314-1319.
19. 125I-labeled anticytokeratin and antiP-LAP monoclonal antibodies. Anticancer Res 1991; 11:555-560.
20. Millan JL, Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem 1983; 136:1-7.
21. Sundstrom BE, Nathrath WB, Stigbrand TI. Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies. J Histochem Cytochem. 1989; 37:1845-1854.
22. Carlsson L, Folkersen J, Stigbrand T. Antigenic determinants of pregnancy-associated alpha 2-glycoprotein and alpha 2-macroglobulin defined by poly- and monoclonal antibodies. Mol Immunol 1985; 22:1073-1080.
23. Hunter WM, Greenwood FC. A radio-immunoelectrophoretic assay for human growth hormone. Biochem J 1964; 91:43-56.
24. Riklund Ahlstrom K, Ullen A, Makiya R, Sundstrom B, Thornell LE, T S. Radioimmunotherapy of HeLa cell tumors in nude mice by a combination of iodine-131-labelled monoclonal antibodies against placental alkaline phosphatase and cytokeratin. Tumor Targeting 1995; 1:239-244.
25. 131I-labeled monoclonal antibodies. Anticancer Res 1990; 10:379-384.
26. St-Jacques S, Cymerman U, Pece N, Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology 1994; 134:2645-2657.
27. 67Cu-21T-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm 2001; 16:213-225.
28. Mattes MJ, Griffiths GL, Diril H, Goldenberg DM, Ong GL, Shih LB. Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells. Cancer 1994; 73:787-793.
29. Sundstrom B, Johansson B, Hietala SO, Stigbrand T. Radioimmunolocalization in nude mice using anticytokeratin monoclonal antibodies. Tumour Biol 1990; 11:158-166.
30. Lee JD, Yang WI, Lee MG, Ryu YH, Park JH, Shin KH, Kim GE, Suh CO, Seong JS, Han BH, Choi CW, Kim EH, Kim KH, Park KB. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide. Eur J Nucl Med Mol Imaging 2002; 29:221-230.
31. McCluggage WG, Lyness RW, Atkinson RJ, Dobbs SP, Harley I, McClelland HR, Price JH. Morphological effects of chemotherapy on ovarian carcinoma. J Clin Pathol 2002; 55:27-31.
32. Paddenberg R, Wulf S, Weber A, Heimann P, Beck LA, Mannherz HG. Internucleosomal DNA fragmentation in cultured cells under conditions reported to induce apoptosis may be caused by mycoplasma endonucleases. Eur J Cell Biol 1996; 71:105-119.
33. Payne CM, Bjore CG Jr, Schultz DA. Change in the frequency of apoptosis after low- and high-dose X-irradiation of human lymphocytes. J Leukoc Biol 1992; 52:433-440.
34. Rydh A, Riklund Ahlstrom K, Widmark A, Johansson L, Nilsson S, Bergh A, Damber JE, Stigbrand T, Hietala SO. Radioimmunoscintigraphy using an anti-prostate monoclonal anti-body (E4): a dosimetric evaluation. Urol Res 2001; 29:216-220.
35. Vanzulli S, Efeyan A, Benavides F, Helguero LA, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A. p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis 2002; 23:749-758.
36. Ruan S, O'Donoghue JA, Larson SM, Finn RD, Jungbluth A, Welt S, Humm JL. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam. J Nucl Med 2000; 41:1905-1912.
37. Shinomiya N. New concepts in radiation-induced apoptosis: 'premitotic apoptosis' and 'postmitotic apoptosis'. J Cell Mol Med 2001; 5:240-253.
38. Znati CA, Rosenstein M, Boucher Y, Epperly MW, Bloomer WD, Jain RK. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res 1996; 56:964-968.
39. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658.
40. Sun LQ, Vogel CA, Mirimanoff RO, Coucke P, Slosman DO, Mach JP, Buchegger F. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice. Cancer Res 1997; 57:1312-1319.
41. Au JL, Jang SH, Zheng J, Chen CT, Song S, Hu L, Wientjes MG. Determinants of drug delivery and transport to solid tumors. J Control Release 2001; 74:31-46.